Curtiss-Wright (CW) CFO executes 1,265-share 10b5-1 stock sale, holds 4,253

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Curtiss-Wright Corporation Executive VP and CFO K. Christopher Farkas reported an open-market sale of 1,265 shares of common stock at an average price of $689.69 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan maintained by his financial advisor. Following this transaction, Farkas directly holds 4,253 shares of Curtiss-Wright common stock. The shares were sold in multiple trades at prices ranging from $681.18 to $699.31 per share.

Insider Trade Summary 10b5-1

Net Seller: 1,265 shares ($872,458)

Net Sell 1 txn

Insider Farkas K Christopher

Role Executive VP and CFO

Sold 1,265 shs ($872K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,265	$689.69	$872K

Holdings After Transaction: Common Stock — 4,253 shares (Direct)

Footnotes (1)

Sale was made in accordance with a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2025 and maintained by the Reporting Person's financial advisor. The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $681.18 to $699.31, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

Form 4 Insider Transactions: What Each Field Means →

03/19/2026 - 04:01 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Farkas K Christopher

(Last)

(First)

(Middle)

C/O CURTISS-WRIGHT CORPORATION

130 HARBOUR PLACE DRIVE

(Street)

DAVIDSON

NORTH CAROLINA

28036

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CURTISS WRIGHT CORP [ CW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Executive VP and CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/18/2026		S⁽¹⁾	V	1,265	D	$689.69⁽²⁾	4,253	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Sale was made in accordance with a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2025 and maintained by the Reporting Person's financial advisor.

2. The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $681.18 to $699.31, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.

Remarks:

	George P. McDonald by Power of Attorney from K. Christopher Farkas	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Curtiss-Wright (CW) report for its CFO?

Curtiss-Wright’s CFO, K. Christopher Farkas, reported selling 1,265 shares of common stock in an open-market transaction. The sale was executed at an average price of $689.69 per share and disclosed in a Form 4 insider trading report.

At what prices did Curtiss-Wright (CW) CFO Farkas sell his shares?

The CFO’s 1,265 Curtiss-Wright shares were sold at prices ranging from $681.18 to $699.31 per share. The Form 4 reports an average selling price of $689.69 per share across these multiple transactions.

Was the Curtiss-Wright (CW) CFO’s stock sale under a Rule 10b5-1 plan?

Yes. The filing states the sale was made in accordance with a Rule 10b5-1 trading plan adopted by K. Christopher Farkas and maintained by his financial advisor, indicating a pre-arranged, scheduled selling program rather than a discretionary trade.

How many Curtiss-Wright (CW) shares does the CFO hold after this sale?

After selling 1,265 shares, Curtiss-Wright’s CFO directly holds 4,253 shares of common stock. This post-transaction ownership figure is reported in the Form 4 and helps indicate the remaining equity stake he retains in the company.

What does the Curtiss-Wright (CW) Form 4 say about trade execution details?

The Form 4 explains that the reported price is an average across multiple trades. Shares were sold in separate transactions between $681.18 and $699.31, and the reporting person undertakes to provide full price-by-trade details to regulators and security holders.